Who was studied?
One patient with primary inferior vena cava leiomyosarcoma.
What does the publication report?
Disease progression was partially controlled despite recurrence and metastases. Multiple interventions contributed to the treatment course.
Safety findings
The abstract does not isolate PRaG-specific safety outcomes.
How should we interpret it?
A single patient cannot establish efficacy or predict an individual outcome. Prior and concurrent treatments limit attribution.
Read the original source
This independently written summary was checked against the publicly available abstract. It is not a translation of the full paper or a clinical recommendation.
Case Report: Multidisciplinary management of primary inferior vena cava leiomyosarcoma: a comprehensive case study · DOI: 10.3389/fonc.2023.1190276 · PMID: 38023228
Educational reporting, not individualized medical advice. Discuss treatment decisions with your clinical team.